Engene Holdings Common Etf Price on November 1, 2023
ENGN Etf | USD 6.61 0.08 1.23% |
If you're considering investing in EnGene Etf, it is important to understand the factors that can impact its price. As of today, the current price of EnGene Holdings stands at 6.61, as last reported on the 9th of September, with the highest price reaching 6.93 and the lowest price hitting 6.41 during the day. enGene Holdings Common secures Sharpe Ratio (or Efficiency) of -0.0587, which denotes the etf had a -0.0587% return per unit of return volatility over the last 3 months. enGene Holdings Common exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm EnGene Holdings' coefficient of variation of (6,543), and Risk Adjusted Performance of (0) to check the risk estimate we provide.
EnGene Etf price history is provided at the adjusted basis, taking into account all of the recent filings.
EnGene |
Sharpe Ratio = -0.0587
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ENGN |
Estimated Market Risk
5.31 actual daily | 47 53% of assets are more volatile |
Expected Return
-0.31 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average EnGene Holdings is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EnGene Holdings by adding EnGene Holdings to a well-diversified portfolio.
Price Book 1.2007 | Book Value 5.502 | Enterprise Value 51.6 M | Enterprise Value Ebitda (6.01) | Shares Float 11.3 M |
EnGene Holdings Main Headline on 1st of November 2023
enGene Launched as Publicly Traded Genetic Medicines Company by finance.yahoo.com
enGene Holdings Inc. today announced the completion of the previously announced business combination between enGene Inc., a clinical-stage genetic medicines company whose lead program is in a pivotal study for BCG-unresponsive non-muscle invasive bladder cancer , and Forbion European Acquisition Corp. , a special purpose acquisition company. The Company also announced a concurrent transaction financing. As a result of the b
EnGene Holdings Valuation on November 1, 2023
It is possible to determine the worth of EnGene Holdings on a given historical date. On November 1, 2023 EnGene was worth 17.91 at the beginning of the trading date compared to the closed value of 20.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of EnGene Holdings etf. Still, in general, we apply an absolute valuation method to find EnGene Holdings' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of EnGene Holdings where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against EnGene Holdings' related companies.
Open | High | Low | Close | Volume | |
22.23 | 22.23 | 17.00 | 21.70 | 60,942 | |
11/01/2023 | 17.91 | 43.00 | 17.89 | 20.00 | 56,703 |
25.14 | 27.99 | 18.50 | 19.00 | 91,875 |
Backtest EnGene Holdings | | | EnGene Holdings History | | | EnGene Holdings Valuation | Previous | Next |
EnGene Holdings Trading Date Momentum on November 1, 2023
On November 02 2023 enGene Holdings Common was traded for 19.00 at the closing time. The top price for the day was 27.99 and the lowest listed price was 18.50 . The trading volume for the day was 91.9 K. The trading history from November 2, 2023 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 5.00% . The trading date delta against the current closing price is 58.85% . |
enGene Holdings Common Fundamentals Correlations and Trends
By evaluating EnGene Holdings' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among EnGene Holdings' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. EnGene financial account trend analysis is a perfect complement when working with valuation or volatility modules.About EnGene Holdings Etf history
EnGene Holdings investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for EnGene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in enGene Holdings Common will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing EnGene Holdings stock prices may prove useful in developing a viable investing in EnGene Holdings
EnGene Holdings Etf Technical Analysis
EnGene Holdings technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
Price Boundaries
EnGene Holdings Period Price Range
Low | September 9, 2024
| High |
0.00 | 0.00 |
enGene Holdings Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
EnGene Holdings September 9, 2024 Market Strength
Market strength indicators help investors to evaluate how EnGene Holdings etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading EnGene Holdings shares will generate the highest return on investment. By undertsting and applying EnGene Holdings etf market strength indicators, traders can identify enGene Holdings Common entry and exit signals to maximize returns
EnGene Holdings Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for EnGene Holdings' price direction in advance. Along with the technical and fundamental analysis of EnGene Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of EnGene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0) | |||
Jensen Alpha | (0.14) | |||
Total Risk Alpha | (0.49) | |||
Treynor Ratio | (0.11) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Other Information on Investing in EnGene Etf
EnGene Holdings financial ratios help investors to determine whether EnGene Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EnGene with respect to the benefits of owning EnGene Holdings security.